KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Other Gross PP&E Adjustments (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Other Gross PP&E Adjustments for 17 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 10.43% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 10.43% increase, with the full-year FY2025 number at $1.6 billion, up 10.43% from a year prior.
  • Other Gross PP&E Adjustments was $1.6 billion for Q4 2025 at Bio-Rad Laboratories, up from -$180.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.6 billion in Q4 2025 to a low of -$190.4 million in Q2 2025.
  • A 5-year average of $743.7 million and a median of $1.3 billion in 2021 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: soared 1014.4% in 2023, then plummeted 113.79% in 2024.
  • Bio-Rad Laboratories' Other Gross PP&E Adjustments stood at -$176.9 million in 2021, then increased by 13.37% to -$153.2 million in 2022, then skyrocketed by 1014.4% to $1.4 billion in 2023, then grew by 5.41% to $1.5 billion in 2024, then rose by 10.43% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BIO's Other Gross PP&E Adjustments are $1.6 billion (Q4 2025), -$180.3 million (Q3 2025), and -$190.4 million (Q2 2025).